Form 4: Alignment Healthcare CFO Sells Shares After PSU Vesting

Robert Thomas Freeman, CFO of Alignment Healthcare, sold shares to cover tax obligations after performance share units vested, while also selling shares under a 10b5-1 plan.

Summary

• Robert Thomas Freeman, the CFO of Alignment Healthcare, acquired 1,020,442 shares of common stock on March 4, 2025, upon the vesting of performance share units (PSUs).
• These PSUs were granted on September 14, 2023, and vested based on the achievement of certain performance objectives related to health plan revenue growth, at-risk returning member medical benefit ratio, and adjusted EBITDA less capital expenditures.
• The performance objectives were achieved above target, leading to 50% of the granted PSUs vesting on March 4, 2025, with the remaining 50% scheduled to vest on December 31, 2025, contingent upon continued service.
• Freeman sold 250,000 shares on March 4, 2025, at a weighted-average price of $15.5831 per share, and 218,295 shares on March 6, 2025, at a weighted-average price of $15.53 per share.
• The sales on March 6, 2025, were to cover tax withholding obligations related to the PSU vesting and do not represent a discretionary trade.
• These sales were executed under a Rule 10b5-1 trading plan adopted on November 25, 2024.
• Following these transactions, Freeman directly owns 1,417,554 shares and indirectly owns 92,929 shares through FCO Holdings LLC.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transactions are routine and related to PSU vesting and tax obligations. The achievement of performance targets is a positive sign, but the share sales could create some short-term uncertainty.

Positives

• The vesting of PSUs indicates that Alignment Healthcare achieved its performance targets related to revenue growth, medical benefit ratio, and adjusted EBITDA.
• The CFO's continued service is incentivized by the remaining 50% of PSUs vesting on December 31, 2025.

Negatives

• The sale of shares by the CFO, even if for tax obligations and under a pre-arranged plan, could be perceived negatively by some investors.

Risks

• Future performance may not meet the targets required for the remaining PSUs to vest on December 31, 2025.
• Sales of shares by insiders, even under 10b5-1 plans, can create short-term price volatility.

Future Outlook

Fifty percent of the granted PSUs will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date.

Industry Context

Insider transactions are common in publicly traded companies, especially following vesting events. The use of 10b5-1 plans is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• Comparing Alignment Healthcare's insider trading activity to similar healthcare companies like Humana or UnitedHealth Group would require analyzing their respective SEC filings for similar patterns of stock sales after vesting events.
• The weighted average price of $15.5831 and $15.53 is within the normal range of stock price fluctuations for a company like Alignment Healthcare.
• The vesting of PSUs based on revenue growth, medical benefit ratio, and adjusted EBITDA is a common practice in the healthcare industry to align management incentives with company performance.

Stakeholder Impact

• Shareholders may experience short-term price volatility due to the share sales.
• Employees may be motivated by the achievement of performance targets and the vesting of PSUs.

Next Steps

• Remaining 50% of PSUs to vest on December 31, 2025, contingent upon continued service.

Key Dates